Site-Selective Suzuki–Miyaura Reaction of 6,8-Dibromoflavone

Dávid Pajtás; Károly Dihen; Tamás Patonay; Krisztina Kónya; Alexander Villinger; Peter Langer

doi:10.1055/s-0035-1560633

Synlett, Inhaltsverzeichnis

Synlett 2015; 26(18): 2601-2605
DOI: 10.1055/s-0035-1560633

letter

Site-Selective Suzuki–Miyaura Reaction of 6,8-Dibromoflavone

Authors

Dávid Pajtás

^aDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
Károly Dihen

^aDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
Tamás Patonay

^aDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
Krisztina Kónya

^aDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
Alexander Villinger

^bDepartment of Chemistry, Organic Chemistry, University of Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany
Peter Langer*

^bDepartment of Chemistry, Organic Chemistry, University of Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany

^cLeibniz-Institute for Catalysis e.V. at the University of Rostock (LIKAT), Albert-Einstein-Str. 3a, 18059 Rostock, Germany

Abstract

Alle Artikel dieser Rubrik

Abstract

8-Aryl- and 6,8-diarylflavones were prepared by Suzuki–Miyaura reactions of 6,8-dibromoflavone. In spite of the greater steric hindrance, the first attack proceeded with good site selectivity at position 8.

Key words

palladium - catalysis - flavones - Suzuki–Miyaura reaction - regioselectivity

Volltext

Referenzen

References and Notes

1a Harborne JB, Baxter H. The Handbook of Natural Flavonoids . Vol. 1. John Wiley and Sons; Chichester: 1999
1b Römpp Lexikon Naturstoffe . Steglich W, Fugmann B, Lang-Fugmann S. Thieme; Stuttgart: 1997
1c Havsteen BH. Pharmacol. Ther. 2002; 96: 67
1d Beecher GR. J. Nutr. 2003; 133: 3248S
1e Middleton Jr E, Kandaswami C, Theoharides TC. Pharmacol. Rev. 2000; 52: 672
1f Harborne JB, Williams CA. Phytochemistry 2000; 55: 481

2a Rao YK, Fang SH, Tzeng YM. Bioorg. Med. Chem. 2005; 13: 6850
2b Wang SF, Jiang Q, Ye YH, Li Y, Tan RX. Bioorg. Med. Chem. 2005; 13: 4880
2c Daskiewies J, Depeint F, Viornery L, Bayet C, Geraldine C, Comte G, Gee J, Johnson I, Ndjoko K, Hostettmann K, Barron D. J. Med. Chem. 2005; 48: 2790
2d Gao H, Kawabata J. Bioorg. Med. Chem. 2005; 13: 1661
2e Gao GY, Li DJ, Keung WM. J. Med. Chem. 2001; 44: 3320

3a Traxler P, Green J, Mett H, Sequin U, Furet P. J. Med. Chem. 1999; 42: 1018
3b Kim YW, Hackett JC, Brueggemeier RW. J. Med. Chem. 2004; 47: 4032
3c Su B, Hackett JC, Diaz-Cruz ES, Kim YW, Brueggemeier RW. Bioorg. Med. Chem. 2005; 13: 6571

4a Cushman M, Zhu H, Geahlen RL, Kraker AJ. J. Med. Chem. 1994; 37: 3353
4b Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M. J. Med. Chem. 1996; 3461
4c Ahn YM, Vogeti L, Liu C.-J, Santhapuram HK. R, White JM, Vasandani V, Mitscher LA, Lushington GH, Hanson PR, Powell DR, Himes RH, Roby KF, Ye Q, Georg GI. Bioorg. Med. Chem. 2007; 15: 702
4d Larget R, Lockhart B, Renard P, Largeron M. Bioorg. Med. Chem. Lett. 2000; 10: 835

5a Konan NA, Lincopan N, Díaz IE. C, de Fatima Jacysyn J, Tiba MM. T, Mendes JG. P. A, Bacchi EM, Spira B. Exp. Toxicol. Pathol. 2012; 64: 435
5b Bedir E, Talti II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan AA. J. Agric. Food Chem. 2002; 50: 3150
5c Beara IN, Lesjak MM, Cetojevic-Simin DD, Marjanovic ZS, Ristic JD, Mrkonjic ZO, Mimica-Dukic NM. Food Chem. 2014; 165: 460
5d Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M, Davisson VJ, Baleja JD, Androphy EJ. PLoS One 2013; 8: e84506
5e Dao TT, Kim SB, Sin K.-S, Kim S, Kim HP, Park H. Arch. Pharm. Res. 2004; 27: 278
5f Lu S, Sun S.-L, Liu H.-C, Chen Y.-D, Yuan H.-L, Gao Y.-P, Lu PY. T. Chem. Biol. Drug. Des. 2012; 80: 328
5g Park H, Dao TT, Kim HP. Eur. J. Med. Chem. 2005; 40: 943
5h Finlay MR. V, Griffin RJ. Bioorg. Med. Chem. Lett. 2012; 22: 5352

6a Miyaura N, Yamada K, Suzuki A. Tetrahedron Lett. 1979; 36: 3437
6b Miyaura N, Suzuki A. Chem. Commun. 1979; 866
6c Miyaura N, Suzuki A. Chem. Rev. 1995; 95: 2457

7a Suzuki A. Pure Appl. Chem. 1985; 57: 1749
7b de Meijere A, Diederich F. Metal-Catalyzed Cross-Coupling Reactions . Wiley-VCH; Weinheim: 2004. 2nd ed., Vol. 1 and 2
7c Beller M, Bolm C. Transition Metals for Organic Synthesis: Building Blocks and Fine Chemicals . Wiley-VCH; Weinheim: 2004. 2nd ed., Vol. 1 and 2
7d Negishi E.-i. Handbook of Organopalladium for Organic Synthesis . Vol. 1 and 2. Wiley-Interscience; New York: 2002
7e Ackermann L. Modern Arylation Methods . Wiley-VCH; Weinheim: 2009
7f Tsuji J. Palladium Reagents and Catalysts . 2nd ed. Wiley; Chichester: 2004
7g King AO, Yasuda N. Organometallics in Process Chemistry . Larsen RD. Springer; Berlin: 2004
7h Suzuki A. Modern Arene Chemistry . Astruc D. Wiley-VCH; Weinheim: 2002
7i Miyaura N. Top. Curr. Chem. 2002; 219: 11
7j Suzuki A. J. Organomet. Chem. 2002; 653: 54
7k Roglans A, Pla-Quintana A, Moreno-Mañas M. Chem. Rev. 2006; 106: 4622
7l Hassan J, Sévignon M, Gozzi C, Schulz E, Lemaire M. Chem. Rev. 2002; 102: 1359
7m Yin L, Liebscher J. Chem. Rev. 2007; 107: 133
7n Wu XF, Anberasan P, Neumann H, Beller M. Angew. Chem. Int. Ed. 2010; 49: 9047
7o Corbet J.-P, Mignani G. Chem. Rev. 2006; 106: 2651

8a Rataboul F, Zapf A, Jackstell R, Harkal S, Riermeier T, Monsees A, Dingerdissen U, Beller M. Chem. Eur. J. 2004; 10: 2983
8b Zapf A, Jackstell R, Rataboul F, Riermeier T, Monsees A, Fuhrmann C, Shaikh N, Dingerdissen U, Beller M. Chem. Commun. 2004; 38
8c Wolfe JP, Tomori H, Sadighi JP, Yin J, Buchwald SL. J. Org. Chem. 2000; 65: 1158
8d Nishiyama M, Yamamoto T, Koie Y. Tetrahedron Lett. 1998; 39: 617

9a Hassan Z, Hussain M, Langer P. Synlett 2011; 1827
9b Littke AF, Dai CY, Fu GC. J. Am. Chem. Soc. 2000; 122: 4020
9c Kamikawa T, Hayashi T. Tetrahedron Lett. 1997; 38: 7087
9d Hassan Z, Hussain M, Villinger A, Langer P. Tetrahedron 2012; 68: 6305
9e Roy AH, Hartwig JF. Organometallics 2004; 23: 194
9f Espino G, Kurbangalieva A, Brown JM. Chem. Commun. 2007; 1742

For reviews of site-selective palladium(0)-catalyzed cross-coupling reactions, see:

10a Wang R, Manabe K. Synthesis 2009; 1405
10b Schnürch M, Flasik R, Khan AF, Spina M, Mihovilovic MD, Stanetty P. Eur. J. Org. Chem. 2006; 3283
10c For a simple guide for predicting the site selectivity of palladium-catalyzed cross-coupling reactions based on ¹H NMR spectroscopic data of the nonhalogenated derivatives, see: Handy ST, Zhang Y. Chem. Commun. 2006; 299

11a Zahid H, Patonay T, Langer P. Synlett 2013; 24: 412
11b Malik I, Hussain M, Hung NT, Villinger A, Langer P. Synlett 2010; 2244
11c Eleya N, Malik I, Reimann S, Wittler K, Hein M, Patonay T, Villinger A, Ludwig R, Langer P. Eur. J. Org. Chem. 2012; 1639

12a Blatt AH. Org. React. 1942; 1: 342
12b Patwari SB, Baseer MA, Vibhute YB, Bhusare SR. Tetrahedron Lett. 2003; 44: 4893
12c Singh PP, Thatikonda T, Kumar KA. A, Sawant SD, Singh B, Sharma AK, Sharma PR, Singh D, Vishwakarma RA. J. Org. Chem. 2012; 77: 5823

13a Claisen L, Claparède A. Ber. Dtsch. Chem. Ges. 1881; 14: 2460
13b Schmidt JG. Ber. Dtsch. Chem. Ges. 1881; 14: 1459

14a Fekete S, Patonay T, Silva AM. S, Cavaleiro JA. S. ARKIVOC 2012; (v): 210
14b Dao TT, Chi YS, Kim J, Kim HP, Kim S, Park H. Bioorg. Med. Chem. Lett. 2004; 14: 1165
14c Cabrera M, Simoens M, Falchi G, Lavaggi ML, Piro OE, Castellano EE, Vidal A, Azqueta A, Monge A, Ceráin AL, Sagrera G, Seoane G, Cerecettoa H, González M. Bioorg. Med. Chem. 2007; 15: 3356
14d Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yáñez M, Orallo F, Ortuso F, Alcaro S, Cirilli R, Ferretti R, Sanna ML. Bioorg. Med. Chem. 2010; 18: 1273

15 Procedure for Synthesising 6,8-Diarylflavone Derivatives 6a–g To a mixture of 6,8-dibromoflavone (4, 95 mg, 0.25 mmol), K₃PO₄ (160 mg, 0.75 mmol), and boronic acid 5 (0.75 mmol) in dry dioxane (4 mL), Pd(PPh₃)₄ (17 mg, 0.015 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated in an aluminum heating block till full conversion. The solvent was removed under reduced pressure, and the solid mixture was dissolved in CH₂Cl₂. The solution was submitted to adsorptive filtration on silica gel using CH₂Cl₂ as eluent to remove the inorganic compounds. The CH₂Cl₂ was evaporated; the residue was washed two times with acetone then filtered to give the pure cross-coupled product 6.

16a Procedure for Synthesising 8-Aryl-6-bromoflavone Derivatives 7a–d To a mixture of 6,8-dibromoflavone (4, 95 mg, 0.25 mmol), K₃PO₄ (106 mg, 0.5 mmol), and boronic acid 5 (0.30 mmol) in dry dioxane (4 mL), Pd(PPh₃)₄ (17 mg, 0.015 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated at 80 °C for 48 h in an aluminum heating block. The solvent was removed in vacuum, and the solid mixture was dissolved in CH₂Cl₂. The solution was submitted to adsorptive filtration on silica gel using CH₂Cl₂ as eluent to remove the inorganic compounds. The eluted solution was concentrated then the mixture was purified by column chromatography (eluent: heptane–EtOAc mixture; the ratio is given at the compound) to give the monosubstituted product.
16b ¹H NMR Spectroscopic Data of Flavone ¹H NMR (400 MHz, CDCl₃): δ = 8.24 (d, J = 8.9 Hz, 1 H, 5-H), 7.97–7.89 (m, 2 H, 2′,6′-H), 7.70 (t, J = 8.4 Hz, 1 H, 7-H), 7.58 (d, J = 8.3 Hz, 1 H, 8-H), 7.56–7.50 (m, 3 H, 3′,4′, 5′-H), 7.43 (t, J = 7.5 Hz, 1 H, 6-H), 6.83 (s, 1 H, 3-H).

17 CCDC-1052200 contains all crystallographic details of this publication and is available free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html.
18 Procedure for Synthesizing Differently Substituted 6,8-Diarylflavone Derivatives 9a–d To a mixture of 8-aryl-6-bromoflavones 7c,d (0.10 mmol), K₃PO₄ (54 mg, 0.25 mmol), and boronic acid 5a,e (0.20 mmol) in dry dioxane (4 mL), Pd(PPh₃)₄ (5.8 mg, 0.005 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated at 100 °C for 2 h in an aluminum heating block. The solvent from the crude reaction mixture was removed in vacuum, and the solid residue was dissolved in CH₂Cl₂. The solution was submitted to adsorptive filtration on silica gel using CH₂Cl₂ as eluent to remove the inorganic compounds. The eluted solution was concentrated, then the mixture was purified by column chromatography (eluent: heptane–EtOAc mixture; the ratio is given at the compound) to give the nonsymmetric diarylated product.
19 6,8-Bis(4-methylphenyl)flavone (6a) Starting with 4 (95 mg, 0.25 mmol), K₃PO₄ (160 mg, 0.75 mmol), Pd(PPh₃)₄ (17 mg, 0.015 mmol, 6 mol%), (4-methylphenyl)boronic acid (5a, 102 mg, 0.75 mmol), and 1,4-dioxane (4 mL), 6a was isolated as a light yellow solid (94 mg 93%), mp 247.0–248.5 °C. ¹H NMR (300 MHz, 298 K, CDCl₃): δ = 8.44 (d, J = 2.7 Hz, 1 H, 5-H), 7.96 (d, J = 2.4 Hz, 1 H, 7-H), 7.82–7.79 (m, 2 H, 2′,6′-H), 7.64–7.59 (m, 4 H, 2′′,6′′-H, 2′′′,6′′′-H), 7.49.7.46 (m, 3 H, 3′,5′-H, 4′-H), 7.37 (d, J = 9.6 Hz, 2 H, 3′′′,5′′′-H), 7.27 (d, J = 9.6 Hz, 2 H, 3′′,5′′-H), 6.96 (s, 1 H, 3-H), 2.50 (s, 3 H, 4′′′-CH₃), 2.42 (s, 3 H, 4′′-CH₃). ¹³C NMR (75 MHz, 298 K, CDCl₃): δ = 178.7 (C-4), 163.2 (C-2), 152.4 (C-8a), 138.1 (C-4′′,4′′′), 137.8 (C-6), 136.4 (C-8), 133.4 (C-7), 133.2 (C-1′′), 132.3 (C-1′′′), 131.6 (C-1′), 131.5 (C-4′), 129.7 (C-3′′,5′′), 129.5 (C-3′′′,5′′′), 129.1 (C-2′′′,6′′′), 129.0 (C-3′,5′), 127.0 (C-2′′,6′′), 126.3 (C-2′,6′), 124.5 (C-4a), 122.1 (C-5), 126.9 (C-3), 21.3 (4′′′-CH₃), 21.1 (4′′-CH₃). IR (ATR): ν = 1636, 1597, 1459, 1447, 1363, 1173, 812, 775, 687, 633, 502 cm^–1. GC-MS (EI, 70eV): m/z (%) = 402 (100) [M^+•], 300, 229, 102. HRMS: m/z calcd for C₂₉H₂₂O₂: 402.16143; found: 402.16156. 6-Bromo-8-(3,4-dimethoxyphenyl)flavone (7c) Starting with 4 (95 mg, 0.25 mmol), K₃PO₄ (106 mg, 0.5 mmol), Pd(PPh₃)₄ (17 mg, 0.015 mmol, 6 mol%), (3,4-dimethylphenyl)boronic acid (5c, 55 mg, 0.30 mmol), and 1,4-dioxane (4 mL), 7c was isolated as a white solid (62 mg 57%), mp 186.5–188 °C (eluent: heptane–EtOAc, 2:1). ¹H NMR (300 MHz, 298 K, CDCl₃): δ = 8.31 (d, 1 H, J = 2.4 Hz, 5-H), 7.80 (d, 1 H, J = 2.4 Hz, 7-H), 7.77–7.75 (m, 2 H, 2′,6′-H), 7.51–7.45 (m, 3 H, 3′,5′-H, 4′-H), 7.18–7.15 (m, 2 H, 2′′,6′′-H), 7.04 (d, J = 8.1 Hz, 1 H, 5′′-H), 6.88 (s, 1 H, 3-H), 3.99 (s, 3 H, 4′′-OCH₃), 3.88 (s, 3 H, 3′′-OCH₃). ¹³C NMR (75 MHz, 298 K, CDCl₃): δ = 177.1 (C-4), 163.3 (C-2), 151.9 (C-8a), 149.4 (C-3′′), 148.7 (C-4′′), 137.0 (C-7), 133.8 (C-1′′), 131.8 (C-4′), 131.2 (C-1′), 129.0 (C-3′,5′), 127.3 (C-8), 126.9 (C-5), 126.2 (C-2′,6′), 125.6 (C-4a), 122.2 (C-6′′), 118.6 (C-6), 112.6 (C-2′′), 111.1 (C-5′′), 106.9 (C-3), 55.9 (3′′-OCH₃, 4′′-OCH₃). IR: (ATR): ν = 3061, 2999, 2933, 2838, 1637, 1567, 1512, 1452, 1358, 1251, 1224, 1137, 1022, 882, 780, 694, 670, 637, 589 cm^–1. GC-MS (EI, 70eV): m/z (%) = 436 [M^+•], 438 [M^+• + 2], 293, 291, 184, 102. HRMS: m/z calcd for C₂₃H₁₇O₄ ⁷⁹Br: 436.03047; found: 436.03046; m/z calcd for C₂₃H₁₇O₄ ⁸¹Br: 438.02843; found: 438.02866. 6-(4-Chlorophenyl)-8-(3,4-dimethoxyphenyl)flavone (9b) Starting with 7c (44 mg, 0.10 mmol), K₃PO₄ (42 mg, 0.2 mmol), Pd(PPh₃)₄ (5.8 mg, 0.005 mmol, 5 mol%), (4-chlorophenyl)boronic acid (5e, 31 mg, 0.20 mmol), and 1,4-dioxane (4 mL), 9b was isolated as a light yellow solid (38 mg, 81%), mp 228–229 °C (eluent: heptane–EtOAc, 2:1). ¹H NMR (300 MHz, 298 K, CDCl₃): δ = 8.40 (d, J = 3.0 Hz, 1 H, 5-H), 7.90 (d, J = 3.0 Hz, 1 H, 7-H) 7.82–7.90 (m, 2 H, 2′,6′-H), 7.64 (d, J = 8.1 Hz, 2 H, 2′′,6′′-H,) 7.52–7.43 (m, 5 H, 3′,5′-H, 4′-H, 3′′,5′′-H), 7.25–7.21 (m, 2 H, 2′′′,6′′′-H), 7.07 (d, J = 8.1 Hz, 1 H, 5′′′-H), 6.93 (s, 1 H, 3-H), 4.00 (s, 3 H, 4′′′-OCH₃), 3.90 (s, 3 H, 3′′-OCH₃). ¹³C NMR (75 MHz, 298 K, CDCl₃): δ = 178.4 (C-4), 163.2 (C-2), 152.6 (C-8a), 149.3 (C-3′′′), 148.8 (C-4′′′), 137.7 (C-1′′), 136.9 (C-6), 134.1 (C-4′′), 133.1 (C-7), 132.4 (C-1′′′), 131.8 (C-4′), 131.5 (C-1′), 129.2 (C-3′,5′), 129.1 (C-3′′,5′′), 128.6 (C-8), 128.4 (C-2′′,6′′), 126.3 (C-2′,6′), 124.7 (C-4a), 122.3 (C-5), 122.2 (C-6′′′), 112.9 (C-2′′′), 111.2 (C.5′′′), 106.9 (C-3), 56.0 (3′′′-OCH₃, 4′′′-OCH₃). IR (ATR): ν = 2957, 2834, 1640, 1514, 1461, 1243, 1225, 1141, 1029, 821, 688 cm^–1. GC-MS (EI, 70eV): m/z (%) = 468 [M^+•], 470 [M^+• + 2], 425, 323, 189, 102. HRMS: m/z calcd for C₂₉H₂₁O₄ ³⁵Cl: 468.11229; found: 468.11195.

Zusatzmaterial

Supporting Information (PDF)